Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leptin receptor overlapping transcript-like 1 (LEPROTL1), also known as endospanin-2, is a membrane-associated protein homologous to yeast VPS55 and vertebrate endospanins, structurally characterized by a four-helix transmembrane bundle[1]. LEPROTL1 is not a cell surface receptor but is instead localized to endosomal and trans-Golgi compartments, functioning mainly in the regulation of intracellular protein trafficking and controlling the cell surface expression of certain receptors, notably the growth hormone receptor[2][3]. LEPROTL1 negatively regulates growth hormone signaling by promoting the turnover or endosomal retention of the growth hormone receptor, thus reducing its abundance at the cell membrane, a function particularly relevant in liver during periods of nutrient deprivation[2][3]. It is also implicated in the endosome-to-vacuole transport pathway, and interacts with vesicle trafficking-related proteins such as Rab13 and Rab8 as part of the broader endospanin family[1]. LEPROTL1 has no reported direct links to actionable drug targets or biomarker use, and although mutations in related intracellular trafficking pathways may play a role in some rare diseases, direct genetic linkage is currently known only for metaphyseal chondrodysplasia, Schmid type[2]. LEPROTL1 is distinct from the classical leptin receptor (LEPR), though both are encoded by related genes and may have coordinated roles in the modulation of leptin and other receptor signaling[1]. The gene is highly conserved across eukaryotes, suggesting an ancient and fundamental role in vesicular trafficking. It is expressed in many tissues but is not deemed a conventional therapeutic target since no drugs are known to interact with it[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leptin receptor overlapping transcript-like 1 (LEPROTL1).